The Role of Midkine in Diagnosis of Thyroid Cancer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03978351

Enrollment

Registered

2019-06-07

Start date

2019-09-30

Completion date

2020-12-31

Last updated

2019-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid Cancer

Brief summary

1. Evaluation of the role of serum midkine in differentiating malignant from benign thyroid nodule 2. studying the level of serum midkine in relation to different thyroid cancer stages

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

patient with thyroid nodule

Exclusion criteria

1. Other known organ tumour 2. Chemothyrapy 3. Radiothyrapy c. Sample Size Calculation

Design outcomes

Primary

Measure	Time frame
serum midkine levels	Baseline

Contacts

Primary ContactMarwa Hassan, Master

meromoro1010@gmail.com01004748373

Outcome results